Back
71
Day Range
$82.00
$85.45
52-Week Range
$74.52
$218.25
Volume
211
50D / 200D Avg
$105.68
/
$163.67
Prev Close
$85.66
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 77.5 | 0.3 |
| P/B | 34.7 | 2.9 |
| ROE % | 51.8 | 3.7 |
| Net Margin % | 54.1 | 3.8 |
| Rev Growth 5Y % | 33.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$155.00
+81.4%
Forward P/E
49.5
Forward EPS
$1.73
EPS Growth (est.)
+0.0%
Est. Revenue
290 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.00
$0.00 – $0.00
|
540 M | 0 |
| FY2029 |
$3.62
$3.32 – $3.90
|
600 M | 1 |
| FY2028 |
$2.49
$2.28 – $2.68
|
470 M | 1 |
Key Takeaways
Revenue grew 33.08% annually over 5 years — strong growth
Earnings grew 39.16% over the past year
ROE of 51.82% indicates high profitability
Net margin of 54.12% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 103.96M in free cash flow
Growth
Revenue Growth (5Y)
33.08%
Revenue (1Y)31.83%
Earnings (1Y)39.16%
FCF Growth (3Y)33.50%
Quality
Return on Equity
51.82%
ROIC45.60%
Net Margin54.12%
Op. Margin74.03%
Safety
Debt / Equity
0.01
Current Ratio6.49
Interest Coverage0.00
Valuation
P/E Ratio
77.48
P/B Ratio34.74
EV/EBITDA55.55
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 31.83% | Revenue Growth (3Y) | 30.56% |
| Earnings Growth (1Y) | 39.16% | Earnings Growth (3Y) | 37.83% |
| Revenue Growth (5Y) | 33.08% | Earnings Growth (5Y) | 39.02% |
| Profitability | |||
| Revenue (TTM) | 212.91M | Net Income (TTM) | 115.22M |
| ROE | 51.82% | ROA | 34.02% |
| Gross Margin | 99.85% | Operating Margin | 74.03% |
| Net Margin | 54.12% | Free Cash Flow (TTM) | 103.96M |
| ROIC | 45.60% | FCF Growth (3Y) | 33.50% |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 6.49 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 77.48 | P/B Ratio | 34.74 |
| P/S Ratio | 41.93 | PEG Ratio | 6.50 |
| EV/EBITDA | 55.55 | Dividend Yield | 0.00% |
| Market Cap | 8.93B | Enterprise Value | 8.75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 212.91M | 161.50M | 124.90M | 93.46M | 67.88M |
| Net Income | 115.22M | 82.79M | 60.65M | 44.44M | 30.85M |
| EPS (Diluted) | 1.10 | 0.79 | 0.58 | 0.43 | 0.30 |
| Gross Profit | 212.60M | 161.20M | 92.37M | 92.94M | 46.66M |
| Operating Income | 157.61M | 114.84M | 86.20M | 64.93M | 44.42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 338.70M | 257.43M | 202.14M | 157.05M | 125.57M |
| Total Liabilities | 81.74M | 69.70M | 63.36M | 55.32M | 43.89M |
| Shareholders' Equity | 256.96M | 187.73M | 138.78M | 101.73M | 81.68M |
| Total Debt | 2.26M | 2.07M | 1.85M | 2.28M | 2.62M |
| Cash & Equivalents | 174.54M | 60.06M | 91.25M | 63.66M | 42.04M |
| Current Assets | 280.09M | 206.56M | 163.79M | 119.82M | 87.57M |
| Current Liabilities | 43.14M | 34.56M | 30.85M | 26.86M | 17.62M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#47 of 157
Recent Activity
Entered
Growth Investing (Philip Fisher)
Mar 24, 2026